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Abstract
Following an application from Specialised Nutrition Europe (SNE), submitted for authorisation of a
health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of
France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an
opinion on the scientiﬁc substantiation of a health claim related to carbohydrate solutions and
contribute to the improvement of physical performance during a high-intensity and long-lasting
physical exercise. The scope of the application was proposed to fall under a health claim based on
newly developed scientiﬁc evidence. The food proposed by the applicant as the subject of the health
claim is carbohydrate solutions containing glucose, mixtures of glucose and fructose, sucrose and/or
maltodextrins. The Panel considers that carbohydrate solutions are sufﬁciently characterised in relation
to the claimed effect. The claimed effect proposed by the applicant is ‘contribute to the improvement
of physical performance during a high-intensity and long-lasting physical exercise’, which is considered
by the Panel as a beneﬁcial physiological effect. The Panel concludes that a cause and effect
relationship has been established between the consumption of carbohydrate solutions and the
improvement of physical performance during high-intensity and long-lasting physical exercise. The
target population is healthy trained adults performing high-intensity (at least at 65% of the VO2max)
and long-lasting (at least 60 min) physical exercise.
© 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
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Summary
Following an application from Specialised Nutrition Europe (SNE), submitted for authorisation of a
health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of
France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an
opinion on the scientiﬁc substantiation of a health claim related to carbohydrate (CHO) solutions and
contribute to the improvement of physical performance during a high-intensity and long-lasting
physical exercise.
The scope of the application was proposed to fall under a health claim based on newly developed
scientiﬁc evidence.
The general approach of the NDA Panel for the evaluation of health claims applications is outlined
in the EFSA general guidance for stakeholders on health claim applications and the guidance on the
scientiﬁc requirements for health claims related physical performance.
The food proposed by the applicant as the subject of the health claim is CHO solutions. The
Panel considers that CHO solutions (containing glucose, mixtures of glucose and fructose, sucrose and/or
maltodextrins), which are the subject of the health claim, are sufﬁciently characterised in relation to the
claimed effect.
The claimed effect proposed by the applicant is ‘contribute to the improvement of physical
performance during a high-intensity and long-lasting physical exercise’. The proposed target population
is ‘healthy physically active, trained or well-trained adults (male and female) engaged in a high-
intensity exercise lasting more than one hour’. The applicant deﬁnes high-intensity and long-lasting
physical exercises being performed at least at 65% of the VO2max, at maximal effort, or during a time
trial test for at least 60 min. The Panel considers that contribution to the improvement of physical
performance during a high-intensity and long-lasting physical exercise is a beneﬁcial physiological
effect.
A total of 14 human intervention studies investigating the effect of CHO solutions on physical
performance were provided by the applicant. Among these, ﬁve were conducted in non-fasting
conditions after a standardised meal and seven were conducted after an overnight fast. In the
remaining two studies, the nutritional conditions before the test were not sufﬁciently speciﬁed.
The Panel considers that human intervention studies investigating the effects of CHO solutions
compared to water, or the effects of CHO–electrolyte solutions compared to water/electrolyte-matched
solutions, on physical performance could provide evidence for the substantiation of the claim proposed
by the applicant on CHO solutions. The Panel also considers that no conclusions can be drawn from
three of the studies provided for the scientiﬁc substantiation of the claim owing to the lack of control
for the electrolytes present in the test beverages.
In weighing the evidence, the Panel took into account that the consumption of CHO solutions
providing about 30–60 g CHO/h, and up to about 90 g CHO/h when about one-third of the CHO were
in the form of fructose, during high-intensity exercise and long duration physical exercise consistently
improved physical performance in four studies conducted in non-fasting conditions with standardised
feeding protocols before the trial sessions. The Panel also took into account that the effect is
supported by four studies conducted in fasting conditions and by two studies in which the nutritional
status of participants before the test was not sufﬁciently speciﬁed. In addition, the Panel considered
that the mechanisms by which the consumption of CHO solutions during high-intensity and long-lasting
physical exercise could exert the claimed effect are well established.
The Panel concludes that a cause and effect relationship has been established between the
consumption of CHO solutions and the improvement of physical performance during high-intensity and
long-lasting physical exercise.
The following wording reﬂects the scientiﬁc evidence: ‘Carbohydrate solutions can contribute to the
improvement of physical performance during a high-intensity and long-lasting physical exercise in
healthy trained adults’.
In order to obtain the claimed effect, CHO solutions (containing glucose, mixtures of glucose and
fructose, sucrose and/or maltodextrins) should be consumed to provide between 30 and 60 g of CHO/h,
and up to 90 g CHO/h if fructose constitutes about one-third of the CHO mixture. The target population
is healthy trained adults performing high-intensity (at least at 65% of the VO2max) and long-lasting (at
least 60 min) physical exercise.
Glycaemic carbohydrates and improvement of physical performance
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
Regulation (EC) No 1924/20061 harmonises the provisions that relate to nutrition and health claims,
and establishes rules governing the Community authorisation of health claims made on foods. As a
rule, health claims are prohibited unless they comply with the general and speciﬁc requirements of this
Regulation, are authorised in accordance with this Regulation, and are included in the lists of
authorised claims provided for in Articles 13 and 14 thereof. In particular, Article 13(5) of this
Regulation lays down provisions for the addition of claims (other than those referring to the reduction
of disease risk and to children’s development and health) which are based on newly developed
scientiﬁc evidence, or which include a request for the protection of proprietary data, to the Community
list of permitted claims referred to in Article 13(3).
According to Article 18 of this Regulation, an application for inclusion in the Community list of
permitted claims referred to in Article 13(3) shall be submitted by the applicant to the national
competent authority of a Member State, which will make the application and any supplementary
information supplied by the applicant available to the European Food Safety Authority (EFSA).
1.2. Interpretation of the Terms of Reference
EFSA is requested to evaluate the scientiﬁc data submitted by the applicant in accordance with Article
16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an opinion on the
scientiﬁc substantiation of a health claim related to: carbohydrate solutions and contribute to the
improvement of physical performance during a high-intensity and long-lasting physical exercise.
The present opinion does not constitute, and cannot be construed as, an authorisation for the
marketing of carbohydrate solutions, a positive assessment of their safety, nor a decision on whether
carbohydrate solutions are, or are not, classiﬁed as a foodstuff. It should be noted that such an
assessment is not foreseen in the framework of Regulation (EC) No 1924/2006.
It should also be highlighted that the scope, the proposed wording of the claim, and the conditions
of use as proposed by the applicant may be subject to changes, pending the outcome of the
authorisation procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006.
2. Data and methodologies
2.1. Data
Information provided by the applicant
Food/constituent as stated by the applicant
According to the applicant, the food for which the health claim is made is ‘glycaemic carbohydrates.
Glycaemic carbohydrates can be classiﬁed, according to their degree of polymerisation, as simple
(monosaccharides and disaccharides) or complex (oligosaccharides and polysaccharides). Glycaemic
carbohydrates are digested and absorbed in the human small intestine, and provide glucose to body
cells as a source of energy’.
Health relationship as claimed by the applicant
According to the applicant, the claimed effect relates to: ‘Physical performance relates to the ability
to complete certain physical tasks with higher intensity, faster, or with a higher power output.
According to the EFSA, improvement of physical performance may be a beneﬁcial physiological effect
for individuals performing physical exercise, either athletes preparing for a competition or during a
competition, or individuals engaged in physical work or recreational activities, especially during a high-
intensity (performed at a minimal of 65% of the VO2 max of the subjects, or at maximal effort, or
during time trial test) and long-lasting (longer than one hour) physical exercise. The outcome variables
of physical performance used to assess the claimed effect are time spent to run or cycle a certain
distance or distance cycled or run during a certain time, which are considered as appropriate outcome
measures by the EFSA. The methods of measurement are adequate methods to easily measure time
or a distance: chronometer or distance-measuring equipment’.
1 Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health
claims made on foods. OJ L 404, 30.12.2006, p. 9–25.
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Mechanism by which the food/constituent could exert the claimed effect as proposed by
the applicant
The applicant claims that ‘There are several mechanisms by which CHO feeding during physical
exercise may improve physical performance. These include 1/maintaining blood glucose and high levels
of CHO oxidation, 2/sparing endogenous glycogen, 3/synthesizing glycogen during low-intensity
exercise, or 4/a central effect of CHO. The mechanisms may be different for relatively short-duration
( 1 h) high-intensity exercise (80–85% of VO2max) than for long-duration (> 2 h) low- to moderate-
intensity exercise (60–75% of VO2max)’.
Wording of the health claim as proposed by the applicant
The applicant has proposed the following wording for the health claim: ‘Glycaemic carbohydrate
intake during a high-intensity and long-lasting physical exercise contributes to the improvement of
physical performance’.
Speciﬁc conditions of use as proposed by the applicant
According to the applicant, the target population for the intended health claim are healthy physically
active, trained or well-trained adults (male and female) engaged in a high-intensity exercise lasting more
than one hour. The doses of glycaemic carbohydrates consumed during a high-intensity and long-lasting
physical exercise to achieve a signiﬁcant effect are 24–72 g/h of single glycaemic carbohydrate and up to
100 g/h for a mixture of fructose (30 g/h) with another glycaemic carbohydrate containing glucose (e.g.
maltodextrin, starch or glucose) (24–72 g/h). The glycaemic carbohydrates are intended to be consumed
at regular intervals during a high-intensity and long-lasting physical exercise. A recommended
consumption pattern is to ingest a portion just before exercise (optional) and to ingest the glycaemic
carbohydrates every 15–20 min during exercise.
Data provided by the applicant
Health claim application on glycaemic carbohydrates and contribute to the improvement of physical
performance during a high-intensity and long-lasting physical exercise pursuant to Article 13.5 of
Regulation 1924/2006, presented in a common and structured format as outlined in the Scientiﬁc and
technical guidance for the preparation and presentation of applications for authorisation of health claims.2
As outlined in the General guidance for stakeholders on health claim applications,3 it is the
responsibility of the applicant to provide the totality of the available evidence.
2.2. Methodologies
The general approach of the NDA Panel for the evaluation of health claims applications is outlined
in the EFSA general guidance for stakeholders on health claim applications (EFSA NDA Panel, 2016).
The scientiﬁc requirements for health claims related to endurance performance are outlined in a
speciﬁc EFSA guidance on health claims on physical performance (EFSA NDA Panel, 2012).
The application does not contain data claimed as proprietary and conﬁdential.
3. Assessment
3.1. Characterisation of the food/constituent
The food/constituent proposed by the applicant as the subject of the health claim is ‘glycaemic
carbohydrates’.
Glycaemic carbohydrates provide carbohydrate, mainly in the form of glucose, to body cells. The
main glycaemic carbohydrates are glucose and fructose (monosaccharides), sucrose and lactose
(disaccharides), as well as malto-oligosaccharides and starch (polysaccharides) (FAO/WHO, 1998; EFSA
NDA Panel, 2010).
Upon a request from EFSA, the applicant clariﬁed that the human intervention studies provided for
the substantiation of the claim had tested the effects of sugars (glucose, mixtures of glucose and
fructose, sucrose) and maltodextrins in liquid form, and therefore the food/constituent for which the
2 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientiﬁc and technical guidance for the preparation and
presentation of an application for authorisation of a health claim (revision 1). EFSA Journal 2011;9(5):2170, 36 pp. https://doi.
org/10.2903/j.efsa.2011.2170
3 EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2016. General scientiﬁc guidance for stakeholders
on health claim applications. EFSA Journal 2016;14(1):4367, 38 pp. https://doi.org/10.2903/j.efsa.2016.4367
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claim is requested are the glycaemic carbohydrates glucose, mixtures of glucose and fructose, sucrose
and maltodextrins in liquid form.
The Panel considers that carbohydrate (CHO) solutions (containing glucose, mixtures of glucose
and fructose, sucrose and/or maltodextrins), which are the subject of the health claim, are sufﬁciently
characterised in relation to the claimed effect.
3.2. Relevance of the claimed effect to human health
The claimed effect proposed by the applicant is ‘improvement of physical performance during a
high-intensity and long-lasting physical exercise’. The proposed target population are ‘healthy
physically active, trained or well-trained adults (male and female) engaged in a high-intensity exercise
lasting more than one hour’.
Physical performance relates to the ability to complete certain physical tasks with higher intensity,
faster, or with a higher power output. Measures of physical performance are obtained in the context of
time-limited or task-limited physical activities (e.g. time spent to run a certain distance, maximal
distance cycled during a speciﬁed time resulting in a higher average power output).
The applicant deﬁnes high-intensity and long-lasting physical exercises being performed at least at
65% of the VO2max, at maximal effort, or during a time trial test for at least 60 min.
The Panel considers that contribution to the improvement of physical performance during a high-
intensity and long-lasting physical exercise is a beneﬁcial physiological effect.
3.3. Scientiﬁc substantiation of the claimed effect
A health claim on carbohydrate–electrolyte solutions and maintenance of endurance performance
pursuant to Article 13(1) of Regulation (EC) No 1924/2006 was assessed by the Panel with a positive
outcome (EFSA NDA Panel, 2011a,b). In order to bear the claim, carbohydrate–electrolyte solutions
should contain 80–350 kcal/L from carbohydrates, and at least 75% of the energy should be derived
from carbohydrates which induce a high glycaemic response, such as glucose, glucose polymers and
sucrose. In addition, these beverages should contain between 20 mmol/L (460 mg/L) and 50 mmol/L
(1,150 mg/L) of sodium, and have an osmolality between 200 and 330 mOsm/kg water. The target
population was active individuals performing endurance exercise.
The Panel also evaluated a health claim related to CHO solutions and maintenance of physical
performance during endurance exercise pursuant to Article 13(5) of Regulation (EC) No 1924/2006
with a negative outcome because the characterisation of the intervention(s) and the comparator(s)
used in each study submitted for the substantiation of the claim was unclear (EFSA NDA Panel, 2014).
The applicant performed a literature search in Medline and CAB Abstracts databases with the following
key words: physical activity/or exercise/or sport/or sports/or athletics/or ball games/or bicycling/or
combative sports/or competitive sports/or gymnastics/or winter sports/or physical ﬁtness/or (sport* or
“physical activity” or “physical activities” or exercise* or running* or walking* or cycling* or bicycling*) AND
sport performance/or athletic performance/or performance AND carbohydrate loading/or carbohydrates/ad
or sugars/ad or dietary carbohydrates/or dietary carbohydrate/or maltodextrins/or sucrose/ad or Dietary
Sucrose/ad or oligosaccharides/ad or glucose/ad or monosaccharides/ad or polysaccharides/ad or fructose/
ad or (CHO or carbohydrate* or glucose or fructose or sucrose or monosaccharide* or oligosaccharide* or
maltodextrin* or sugar*) AND (supplementation or consumption or administration or ingestion or ingesting
or intake or receiving or dose* or dosage) NOT mouth rins*. The literature search was limited to articles
published from the year 2000.
The applicant identiﬁed 10 published human intervention studies as being pertinent to the claim.
The majority of the human intervention studies provided, however, was conducted after an overnight
fast, a condition under which high-intensity and long-lasting physical exercise is generally not
undertaken. Upon a request from EFSA, the applicant performed an additional literature search and
provided four additional human intervention studies published before 2000.
A total of 14 human intervention studies investigating the effect of CHO solutions on physical
performance were provided by the applicant. Among these, ﬁve were conducted in non-fasting conditions
after a standardised meal (Mitchell et al., 1988, 1989; Langenfeld et al., 1994; Desbrow et al., 2004;
Baur et al., 2014) and seven were conducted after an overnight fast (Campbell et al., 2001; Currell and
Jeukendruop, 2008; Siahkohian et al., 2008; Currell and Robson-Ansley et al., 2009; Smith et al., 2010;
Roberts et al., 2014; Newell et al., 2015). In the remaining two studies, the nutritional conditions before
the test were not sufﬁciently speciﬁed (El-Sayed et al., 1995; MacLaren and Close, 2000).
Glycaemic carbohydrates and improvement of physical performance
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The Panel considers that human intervention studies investigating the effects of CHO solutions
compared to water, or the effects of CHO–electrolyte solutions compared to water/electrolyte-matched
solutions, on physical performance could provide evidence for the substantiation of the claim proposed
by the applicant on CHO solutions as characterised in Section 3.1.
Two of the seven studies provided conducted after an overnight fast (Roberts et al., 2014; Newell
et al., 2015) investigated the effects of CHO–electrolyte solutions (containing about 370–800 mg/L of
sodium) on physical performance against a water placebo with no sodium. The Panel notes that CHO–
electrolyte solutions containing between 20 mmol/L (460 mg/L) and 50 mmol/L (1,150 mg/L) of
sodium have shown to be effective in maintaining endurance performance compared to plain water,
and that sodium plays a major role in maintaining ﬂuid and electrolyte balance during prolonged
exercise (EFSA NDA Panel, 2011a). In this context, the Panel notes that plain water is not an
appropriate control to investigate the effect of CHO in CHO–electrolyte solutions on performance, and
therefore considers that no conclusions can be drawn from these studies for the scientiﬁc
substantiation of the claim.
One of the ﬁve studies conducted in non-fasting conditions after a standardised meal (Desbrow
et al., 2004) evaluated the effect of a CHO–electrolyte solution (Gatorade, Quaker Oats, 6% CHO) vs
an artiﬁcially sweetened placebo on a time-trial cycling performance. The Panel notes that the precise
CHO mixture in the 6% CHO solution was not reported. The Panel also notes that the electrolytes
present in the 6% CHO solution were not controlled for in the placebo beverage. The Panel considers
that no conclusions can be drawn from this study for the scientiﬁc substantiation of the claim.
It is well established that the limiting step in the oxidation of exogenous carbohydrates ingested
during exercise is their absorption in the small intestine. Glucose (consumed as such or as glucose
polymers, such as maltodextrins) is absorbed via a sodium-dependent transporter (SGLT1), which
becomes saturated at a carbohydrate intake of around 60 g/h, whereas fructose is absorbed by
facilitated diffusion (GLUT5). Unabsorbed glucose in the small intestine may lead to gastrointestinal
symptoms and impair water absorption during exercise. The Panel notes that, in some of the
remaining studies submitted for the substantiation of the claim (n = 11), glucose was provided in CHO
solutions at a rate (about 90 g/h or more) which exceeded the absorption capacity of the small
intestine, and that this is outside the conditions of use proposed by the applicant.
Human intervention studies conducted in non-fasting conditions after a standardised meal
Four human intervention studies investigated the effect of CHO solutions on endurance
performance in non-fasting conditions after a standardised meal (Mitchell et al., 1988, 1989;
Langenfeld et al., 1994; Baur et al., 2014).
Mitchell et al. (1988) tested the effect of three CHO solutions (containing 5%, 6% and 7.5% of
carbohydrates) against a water placebo on gastric emptying and physical performance in a
randomised, four-period, single-blind, cross-over study.
The 5% CHO solution contained 2.7 g of maltrin and 2.3 g of glucose per 100 mL, whereas the 6%
CHO solution contained 2.14 g of maltrin, 1.88 g of fructose and 1.95 g of sucrose per 100 mL and
the 7.5% CHO solution had 5.5 g of maltrin and 2 g of glucose per 100 mL. The doses of CHO tested
were 33.5, 39.4 and 50.1 g/h, respectively.
Eight trained male cyclists (mean age 21.5  0.67 years, VO2max 4.7  0.13 L) performed four
trials of 8 intermittent bouts at 70% VO2max lasting 12 min each with a 3-min rest between each bout.
During the ﬁnal 12-min self-paced maximal ride, total work output was assessed. The total duration of
performance was 108 min. The day before each trial, subjects consumed a standard mixed meal
containing 3,000 kcal and 400 g of CHO. The day of the test, subjects consumed a standard breakfast
providing 740 kcal and 116 g of CHO 4–6 h before the trial. The test solutions were consumed at a
rate of 8.5 mL/kg per h prior to each 12-min bout (mean total 1,336 mL/2 h).
All data were analysed using a two-way analysis of variance (ANOVA) for repeated measures. The
totalwork output in the ﬁnal 12-min self-paced maximal ride was signiﬁcantly higher in all three
CHO trials compared to the water placebo trial (5% CHO = 1.98  0.09 9 105 Nm; 6%
CHO = 1.96  0.09% x 105 Nm; 7.5% CHO = 2.05  0.13 9 105 Nm; water = 1.83  0.11 9 105 Nm,
p < 0.05 for all three CHO trials against the water placebo trial).
The Panel considers that this study shows an effect of CHO solutions (containing mixtures of
maltodextrins with either glucose or fructose at 5%, 6% and 7% and providing from 33.5, 39.4 and
50 g of CHO/h) on physical performance during a high-intensity physical exercise lasting about
108 min.
Glycaemic carbohydrates and improvement of physical performance
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In another study with a similar design, the same authors (Mitchell et al., 1989) tested the effect of
three CHO solutions (containing 6%, 12% and 18% of CHO) against a water placebo on physical
performance and muscle glycogen utilisation.
The 6% CHO solution contained 4 g of a glucose polymer (dextrose equivalent = 20) and 2 g of
sucrose per 100 mL, whereas the 12% CHO solution contained 8.5 g of the same glucose polymer and
3.5 g of fructose per 100 mL and the 18% CHO solution had 14.5 g of the glucose polymer and 3.5 g
of fructose per 100 mL. The doses of CHO tested were 37.1, 74.1 and 111.2 g/h, respectively. A total
of 10 trained male cyclists (mean age 24.2  1.9 years, mean VO2max = 4.45  0.16 L) were enrolled
in this randomised, ﬁve-period, single-blind, cross-over study. The CHO solutions and the water
placebo were tested in 4 continuous trials where the ﬁrst 105 min were at 70% of VO2max and the
ﬁnal 15 min were an all-out performance ride on an isokinetic cycle ergometer to measure total work
output. The 12% CHO solution was also tested in an intermittent trial, in which seven 15-min rides at
70% VO2max with 3-min rest periods between each ride were used, followed by a 15-min all-out
performance ride. During the ﬁrst 105 min, the participants consumed 8.5 mL/kg per h (~ 150 mL)
every 15 min of one of the tested beverages. As in the previous study, subjects consumed a standard
mixed meal containing about 3,000 kcal (55% CHO, 30% fat, 15% protein) the day before each trial.
A liquid pretest meal (225 mL, 360 kcal, 48 g CHO) was ingested 3 h before each exercise trial. Trials
were separated by 1 week.
All data were analysed using a two-way ANOVA for repeated measures. The subjects performed
signiﬁcantly more work in both trials (continuous and intermittent) with the 12% CHO solution than in
the trial with water placebo (2.28  0.12 and 2.22  0.15 vs 2.01  0.15 Nm x 105; p < 0.05 for
both comparisons). Total work output was not signiﬁcantly different between the trials with the 6% or
the 18% CHO solutions and the water placebo trial.
The Panel notes that the improvement in performance was shown with the 12% CHO solution
providing about 74 g of CHO per hour, either under intermittent or continuous exercise, but not with
the 6% or 18% CHO solutions under continuous exercise. The authors argue that the nature of the
exercise (continuous vs intermittent) does not explain the different results obtained in the previous
study (Mitchell et al., 1988) with 5% and 6% CHO solutions, but rather the fact that these lower doses
of CHO may be borderline to obtain signiﬁcant beneﬁts on performance. The authors also explain that
the lack of effect on performance of the 18% CHO solution may be due to impaired ﬂuid delivery
associated with gastric emptying. The Panel agrees with the explanations given by the authors and
notes that, during the administration of the 18% CHO solution, the dose of glucose (about 90 g/h)
exceeded the absorption capacity of the intestine.
The Panel considers that this study shows an effect of a CHO solution (containing a mixture of
glucose polymers and fructose at 12% and providing about 74 g of CHO/h) on physical performance
during high-intensity and long-lasting physical exercise, either intermittent or continuous. The
Panel also considers that CHO solutions at higher (18%, providing about 111 g of CHO/h) or lower
(6%, providing about 37 g of CHO/h) concentrations did not show an effect on performance during a
high-intensity physical exercise lasting about 120 min.
Langenfeld et al. (1994) studied the effect of a 7% CHO–electrolyte solution (5% maltodextrin and
2% fructose) vs an identical electrolyte solution without CHO (placebo) on physical performance and
blood biochemistry in a two-period, randomised, double-blind, cross-over trial.
Fourteen trained cyclists (mean age 20.6  2.5 years, mean VO2max 55.9  4.7 mL/kg per minute)
were included. For two days before each trial, subjects consumed a standardised diet containing 50%
CHO, 35% fat and 15% protein. A standardised pretest meal was given 3–4 h prior to exercise (energy
and nutritional composition not reported). Trials were performed the same day of the week, one week
separating each trial.
At each trial, participants were requested to cycle 80 miles as fast as possible. Following each
10-mile segment, participants ingested either a non-caloric placebo or the 7% CHO solution within
10 min. The mean intake at each feeding time was 0.25 g CHO/kg body weight (bw), corresponding
to about 260 mL and 37 g CHO/h). Statistical analysis was performed by ANOVA with Bonferroni
corrections for multiple comparisons. Total mean ﬁnishing times were signiﬁcantly lower with the 7%
CHO solution than with placebo (241.0  2.1 min vs 253.2  2.1 min, p < 0.05). Signiﬁcant
differences were also observed for split times at 60 and 70 miles.
The Panel notes that duration of the exercise in this study was very long (about 4 h) and that the
intensity (never exceeding 65% of the VO2max) was more moderate as compared to other studies.
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The Panel considers that this study shows an effect of a CHO solution (a mixture of maltodextrins
and fructose at 7% and providing about 37 g of CHO/h) on physical performance during a moderate
to high intensity physical exercise lasting about 4 h.
Baur et al. (2014) investigated the effect of three different CHO–electrolyte solutions vs a water–
electrolyte solution on performance during a cycling time trial in a randomised, four-period, double-
blind, placebo-controlled cross-over study.
Ten male endurance trained cyclists and triathletes (mean age 25  6 years, VO2max > 55 mL/kg
per minute) were included. Subjects were asked to record food consumption for 24-h prior each trial,
to replicate their food intake for the 24 h preceding the subsequent trial, to consume a meal
replacement the night before the trial (providing 20–25% of their estimated energy expenditure) and
to consume a standard breakfast 2 h before each trial, providing about 500 kcal.
The experimental trials on cycle ergometer consisted of 120 min of constant-load cycling at 55%
Wmax (195  6 W), followed by a simulated 30-km time trial with a maximal effort. The whole exercise
lasted about 3 h. Trials were separated by 6–14 days. During each trial, subjects consumed a total of
2,250 mL of one of four beverages (600 mL before exercise and 150 mL every 15 min during the
constant-load part of the trial and at 7.5, 15 and 22.5 km during the 30-km time trial). The beverages
were a 12% glucose-fructose solution (2:1 ratio) and a 12% glucose solution, both providing 95.3 g
CHO/h, an 8% glucose solution providing 63.5 g CHO/h, and artiﬁcially sweetened water. Each
beverage (including the control) also contained 470 mg/L of sodium chloride and 200 mg/L of
potassium chloride.
Performance was assessed by the time spent to ﬁnish the 30-km time trial and by the mean power
output during this trial. Data were analysed by univariate ANOVA. Eight participants completed the
study (drop-outs unrelated to the study).
Compared to placebo, the time spent to complete the time trial was signiﬁcantly shorter (all
p < 0.05) and the power output signiﬁcantly higher for the 8% glucose solution and the 12% glucose-
fructose solution (52.9  3.7 min (217  40 W) vs 51.1  2.4 min (237  30 W) and 50.4  2.2 min
(244  27 W), respectively, p < 0.05 for all comparisons), but not for the 12% glucose solution, for
which time and power output did not differ signiﬁcantly from placebo. The Panel notes that the
ingestion of glucose during the 12% glucose solution trial (95.3 g glucose/h) was likely to exceed the
absorption capacity of the intestine.
The Panel considers that this study shows an effect of CHO solutions (containing either glucose at
8% providing 63.5 g CHO/h or mixture of glucose and fructose at 12% providing 95.3 g of CHO/h) on
physical performance during a high-intensity physical exercise lasting about 180 min.
The Panel notes that the consumption of CHO solutions during high-intensity exercise (lasting about
1.5 h or more) consistently improved physical performance in the four studies from which conclusions
could be drawn that were conducted in non-fasting conditions and used standardised feeding protocols
before the trial sessions (Mitchell et al., 1988, 1989; Langenfeld et al., 1994; Baur et al., 2014). The
effect was consistently shown in two studies (Mitchell et al., 1989; Baur et al., 2014) for CHO solutions
providing about 60 g CHO/h and up to about 90 g CHO/h when about one-third of the CHO were in
the form of fructose, whereas solutions providing only glucose at rates of about 90 g/h consistently
showed no effect on performance as compared to placebo in these two studies. The effect of CHO
solutions providing lower CHO doses (between 33 and 50 g CHO/h) was investigated in three studies
(Mitchell et al., 1988, 1989; Langenfeld et al., 1994), two of which showed a signiﬁcant effect on
physical performance (Mitchell et al., 1988; Langenfeld et al., 1994). The Panel also notes that the rate
of CHO consumption needed to achieve the claimed effect may depend on the intensity and duration
of the exercise performed, as well as on the training status of the subjects and their dependence of
CHO as source of energy.
Human intervention studies conducted after an overnight fast
Five human intervention studies investigated the effect of CHO solutions on endurance performance
after an overnight fast (Campbell et al., 2001; Currell and Jeukendrup, 2008; Siahkohian et al., 2008;
Robson-Ansley et al., 2009; Smith et al., 2010).
In two studies (Currell and Jeukendrup, 2008; Siahkohian et al., 2008), the nutritional status of the
study subjects prior to the performance test was not speciﬁed in the publications. However, the
Panel notes that the tests were performed early in the morning, and that blood glucose concentrations
at baseline were compatible with the fasted state.
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Siahkohian et al. (2008) evaluated the effect of a 5% CHO solution vs a placebo solution
(composition not speciﬁed) on 200-m sprint performance in a randomised, double-blind, two-arm,
parallel study.
A total of 30 young active men participated in the study (n = 15 per group). The trials consisted of
a 200-m sprint (pre-test), a 90-min running at 70–80% of maximal heart rate reserve and a 200-m
sprint immediately after. Performance was measured as the time spent to complete the 200-m sprint.
During the trials, participants consumed either a 5% CHO solution (sucrose) or the placebo
solution. The solutions were given at 10-min intervals throughout the 90-min exercise in a volume of
3 mL/kg bw, corresponding to 1,900–2,100 mL during the whole trial (about 67 g of CHO/h).
Independent t-tests were used to compare 200-m sprint times between groups at baseline and at
the end of the trial. The mean time to complete the second 200-m sprint was signiﬁcantly lower in the
group consuming the 5% CHO solution than in the placebo group (28.94  2.64 s vs 30.67  1.95 s,
p = 0.025), with no differences between groups at baseline (27.85  1.57 s vs 28.21  1.94 s). The
Panel notes, however, that baseline values account for about half of the difference observed between
groups at the end of the trial and considers that the statistical analysis, which does not take into
account baseline values, does not allow drawing conclusions from this study.
The Panel considers that no conclusions can be drawn from this study for the scientiﬁc
substantiation of the claim.
In a randomised, placebo-controlled, three-period, cross-over study, Currell and Jeukendrup (2008)
compared the effect of two CHO solutions at 14.4% (glucose alone or glucose and fructose at a ratio
of 2:1) vs a water placebo on endurance cycling performance. No references to blinding procedures
are reported in the publication. The Panel assumes that this was an open-label study.
Eight trained male cyclists (mean age 32  7 years, mean VO2max 64.7  3.9 mL/kg per minute,
mean Wmax 364  31 W) were recruited for the study. Subjects completed the three experimental
trials in a randomised order. Each trial was separated by 7–14 days. Subjects cycled ﬁrst for 2 h at an
intensity of 55% Wmax, with a cycle ergometer set in cadence-independent mode. Then, the cycle
ergometer was set to linear mode (workload increases as the pedalling rate increases) and participants
were asked to perform a certain amount of work (about 60 min of cycling at 75% Wmax) as fast as
possible. During the exercise, the subjects received continuous information about the recorded power
output, cadence, and total work completed. The mean power output during the trial, the time to
complete the trial work, VO2, expiratory exchange ratio (RER), plasma lactate and glucose, heart rate,
cadence and rating of perceived exertion (RPE) were measured.
A 600-mL bolus of the beverages was administered before the beginning of exercise, then 150 mL
of the beverages were consumed every 15 min throughout the steady-state period and at 25, 50, and
75% of the time trial. The 14.4% CHO solutions were given at a rate of 1.8 g/min. The glucose
solution provided 108 g of glucose/h, whereas the glucose/fructose solution provided 72 g of glucose
and 36 g of fructose per h.
A two-way repeated measures-ANOVA (RM-ANOVA) was used for the statistical analysis. In case of
signiﬁcant differences being identiﬁed, post hoc analysis were undertaken with Tukey’s honest
signiﬁcant difference (HSD) test.
The mean power output during the trial was signiﬁcantly higher for the glucose (254  8 W) and
the glucose/fructose (275  10 W) solutions than for placebo (231  9 W; p < 0.05 for both
comparisons), whereas the time to complete the target work was signiﬁcantly lower for the glucose
and the glucose/fructose solutions than for placebo. The mean power output during the trial was also
signiﬁcantly higher and the time to complete the target work signiﬁcantly lower for the glucose/
fructose solution as compared to the glucose solution.
The Panel considers that this study shows an effect of CHO solutions (at 14.4%, containing glucose
or glucose and fructose at a ratio of 2:1, and providing about 108 g CHO/h) on physical performance
during a high-intensity physical exercise lasting about 180 min. The Panel also notes that the 14.4%
glucose solution was likely to exceed the absorption capacity of the intestine.
Campbell et al. (2001) studied the effect of a 6% CHO solution vs water on glucose kinetics and
physical exercise performance during the follicular and luteal phases of the menstrual cycle in a
randomised, double-blind, four-period, cross-over study.
The study was performed in a group of eight healthy, non-smoking, eumenorrheic, endurance-
trained women (aged 24  2 years) with VO2peak ≥ 50 mL/kg per min. Four experiments were
conducted over the course of at least two menstrual cycles, during the follicular and luteal phases of
the menstrual cycle, with glucose or placebo in a random order. The experiments were performed in
the morning in fasting conditions.
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Participants cycled for two hours at 70% VO2peak and then completed a 4 kJ/kg bw time trial as
quickly as possible. The subjects were asked to drink 400 mL of a beverage at the start of the exercise
and additionally 230 mL every 15 min for the entire steady-state exercise period. Beverages contained
a 6% glucose solution providing 55.4 g glucose/hour or ﬂavour-matched water. The measure of
performance was the time to complete the time trial.
All statistical comparisons were made using two- or three-way ANOVA. Speciﬁc differences were
tested with a Newman–Keuls F-test.
Consumption of the 6% glucose solution decreased the time taken to perform the time trial by
19% in the follicular phase (19:53  0:52 vs. 24:30  2:07 min: sec) and by 26% in the luteal phase
(20:55  0:56 vs. 28:17  3:13 min: sec) compared to the water control (p < 0.05 for both
comparisons).
The Panel considers that this study shows an effect of a CHO solution (containing glucose at 6%
and providing about 55 g CHO/h) on physical performance in women during a high-intensity physical
exercise lasting about 140 min, regardless the menstrual phase.
Robson-Ansley et al. (2009), using a randomised, two-period, placebo-controlled, double-blind,
cross-over design, investigated the effect of an 8% CHO solution (maltodextrin) vs a ﬂavoured water
placebo on the interleukin-6 (IL-6) response to a 90-min running time trial (primary outcome).
Performance was assessed as the distance run in the time trial (secondary outcome).
Seven recreationally trained male runners (mean age 24  4 years) performed two times, each
separated by one week, a 90-min self-paced time trials on a treadmill after an overnight fast. The
participants consumed a ﬂuid bolus of 8 mL/kg bw followed by 2 mL/kg bw every 20 min throughout
the exercise of the 8% CHO solution (providing about 63 g of CHO/h) or the placebo solution in a
randomised order. The participants were not aware of the distance completed during the exercise.
RM ANOVA or paired Student’s t-test were used in statistical analysis. When signiﬁcance was
identiﬁed with the RM-ANOVA, a Tukey–Kramer post hoc test for multiple comparisons was performed
to determine the minimum signiﬁcant difference (MSD). The q-value from each pairwise comparison
was compared against the MSD to determine signiﬁcance.
The distance covered in the 90-min run was signiﬁcantly greater during the 8% CHO solution trial
than during the placebo trial (19.13  1.7 km vs 18.29  1.9 km, p = 0.0022).
The Panel considers that this study shows an effect of a CHO solution (containing maltodextrin at
8% and providing about 63 g CHO/h) on physical performance during a high-intensity physical exercise
lasting about 90 min.
Smith et al. (2010) investigated the effect of CHO–electrolyte solutions containing different
amounts of glucose (1.5%, 3% and 6%) vs a water-electrolyte solution on endurance performance in
a four-period, single-blind (subjects blinded), placebo-controlled, cross-over study.
Twelve trained recreational male cyclists or triathletes (mean age 31.7  3.8 years and VO2peak
55.3  3.6 mL/kg per minute) were recruited for the study. Participants completed four exercise trials
after an over-night fast, with at least 7 days between trials. Each exercise trial began with a 2-h
constant load bicycle ride (average workload 228  26 W or 77  5% VO2peak). It was followed by a
20-km time trial in which participants were asked to cover the distance as quickly as possible. During
the ﬁrst part of the exercise (2-h ride), participants ingested 2,000 mL (250 mL every 15 min) of one
of the four beverages: a water–electrolyte solution (18 mmol/L Na+, 3 mmol/L K+ and 11 mmol/L
Cl), or the same water–electrolyte solution with 1.5%, 3% or 6% glucose (providing 0, 15, 30 or
60 g of CHO/h, respectively). The four beverages were similar in ﬂavour and appearance. No ﬂuid was
ingested during the 20-km time trial. The total time of the exercise was about 150 min. Mean power
output was recorded to assess the effect on performance.
Between-treatment differences were assessed by one-way (dose or time) and two-way (dose 9 time)
RM-ANOVA and Duncan’s post hoc comparisons, when appropriate.
The consumption of the glucose solutions signiﬁcantly decreased the time to complete the 20-km
time trial (1.5% glucose: 35.2  2.8 min; 3% glucose: 35.0  2.6 min; 6% glucose: 34.7  2.1 min)
as compared to placebo (36.4  2.8 min) and signiﬁcantly increased the average power output
accordingly (placebo = 210  36 W; 1.5% = 225  40 W, p = 0.014; 3% = 227  40 W, p = 0.009;
6% = 232  34 W, p = 0.001), with no signiﬁcant differences among the different glucose solutions.
The Panel considers that this study shows an effect of CHO solutions (containing glucose at 1.5, 3
and 6% and providing 15, 30 and 60 g CHO/h) on physical performance during a high-intensity
physical exercise lasting about 150 min.
The Panel considers that the four studies conducted after an overnight fast from which conclusions
can be drawn for the scientiﬁc substantiation of the claim (Campbell et al., 2001; Currell and
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Jeukendrup, 2008; Robson-Ansley et al., 2009; Smith et al., 2010) support an effect of CHO solutions
on physical performance during high-intensity, long-lasting physical exercise. The Panel considers,
however, that these studies cannot be used to establish conditions of use for the claim because high-
intensity and long-lasting physical exercises are generally not undertaken after an overnight fast.
Human intervention studies conducted under poorly speciﬁed nutritional conditions
Two human intervention studies investigated the effect of CHO solutions on endurance performance
under poorly speciﬁed nutritional conditions (El-Sayed et al., 1995; MacLaren and Close, 2000).
El-Sayed et al. (1995) investigated the effect of an 8% CHO solution (glucose) vs an artiﬁcially
sweetened, orange-ﬂavoured, glucose-free placebo on cycling performance in a randomised, placebo-
controlled, single-blind (for participants), cross-over study.
Nine male cyclists (mean age 23.8  4.4 years, mean VO2max 60.7  2.2 mL/kg per minute) were
enrolled. The participants performed two identical 70-min exercise tests separated by 7 days which
consisted of cycling at 70% of VO2max for 60 min followed by a self-paced maximal ride for 10 min.
Subjects were fasted for 4 h before the exercise test. The study beverages were administered at 20,
40 and 60 min of the exercise (3 mL/kg bw), and provided 33.5 g of CHO/h (CHO solution) and 0 g of
CHO/h (placebo), respectively.
The statistical analysis was performed using two-way RM-ANOVA. When ANOVA showed a
signiﬁcant difference, the Tukey post hoc test was used to investigate which mean values were
signiﬁcantly different.
The distance covered during the 10-min self-paced maximal ride was signiﬁcantly higher during the
8% CHO solution test than during the placebo test (results presented in a graph only, the exact
numbers not given, p < 0.05).
The Panel considers that this study shows an effect of a CHO solution (containing glucose at 8%
and providing about 34 g of CHO/h) on physical performance during a high-intensity physical exercise
lasting about 70 min.
MacLaren and Close (2000) investigated the effect of a 6% CHO solution (maltodextrin) on physical
performance in rugby referees (n = 8, mean age 28.4  1.5 years and an estimated VO2max of
52.2  3.1 mL/kg per min) while undertaking a simulated rugby league game in a placebo controlled,
two-period, single-blind (presumably for participants) study. The order in which the study beverages
were administered was ‘counterbalanced’, as reported in the publication, but it is unclear whether
subjects were randomised to the two possible sequences.
Subjects were asked to keep their dietary intake constant 24-h prior the test and were tested at
the same time of the day (unspeciﬁed) after not consuming any foods or drinks (other than water) for
at least four hours.
During one trial, 200 mL of orange-ﬂavoured 6% CHO solution (maltodextrin) providing 72 g of
CHO/h was ingested at eight time points, while in the other trial a placebo of similar taste was
administered. The trials were separated by 1 week. The simulation of a rugby match involved
performing four 10-min blocks of shuttle activity. Then, after a 10-min break, three further 10-min
blocks of shuttle activity were performed. Timed 15-m sprints took place during each of the 10-min
blocks. Finally, a performance test to exhaustion involving 20-m shuttles at paces varying between
55% and 95% of a predetermined VO2max was undertaken. Fatigue was deemed to have occurred
when subjects were unable to maintain the selected pace for two successive shuttles. The Panel notes
that the number of shuttles to fatigue and the RPE assessed during this last part of the trial are not
measures of physical performance.
Multifactorial RM-ANOVA was used for the statistical analysis of the 15-m sprint times during the
10-min blocks. The mean sprint times for the seven 10-min blocks of 15-m sprints were shorter in the
6% CHO solution trial compared to the placebo trial (2.40  0.09 s vs 2.51  0.14 s; p < 0.05).
The Panel considers that this study shows an effect of a CHO solution (containing maltodextrin at
6% and providing about 72 g of CHO/h) on physical performance during a high-intensity physical
exercise lasting about 70 min.
The Panel considers that the two studies in which the nutritional status of participants before the test
was not sufﬁciently speciﬁed (El-Sayed et al., 1995; MacLaren and Close, 2000) support an effect of CHO
solutions on physical performance during high-intensity physical exercise lasting 70 min or more.
Conclusion on the human intervention studies
The consumption of CHO solutions during high-intensity, long-lasting physical exercise consistently
improved physical performance in the four studies from which conclusions could be drawn that were
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conducted in non-fasting conditions and used standardised feeding protocols before the trial sessions
(Mitchell et al., 1988, 1989; Langenfeld et al., 1994; Baur et al., 2014). In two studies, the effect was
shown for CHO solutions providing about 60 g CHO/h and up to about 90 g CHO/h when about one-
third of the CHO were in the form of fructose, whereas solutions providing only glucose at rates of
about 90 g/h consistently showed no effect on performance as compared to placebo. An effect of CHO
solutions providing lower CHO doses (between 33 and 50 g CHO/h) on performance was shown in two
out of three studies.
The effect of CHO solutions on physical performance during high-intensity, long-lasting physical
exercise is supported by the results of four interventions studies conducted after an overnight fast
(Campbell et al., 2001; Currell and Jeukendrup, 2008; Robson-Ansley et al., 2009; Smith et al., 2010)
and by the results of two intervention studies (El-Sayed et al., 1995; MacLaren and Close, 2000)
conducted after at least a 4-h fast in which the nutritional status of participants before the test was
not otherwise speciﬁed.
The Panel notes that the rate of CHO consumption needed to achieve the claimed effect may
depend on the intensity and duration of the exercise performed, as well as on dietary factors that
affect pre-exercise glycogen stores and on the training status of the individuals undertaking the
exercise.
Mechanism(s) by which the food/constituent could exert the claimed effect
It is well established that carbohydrates are a key energy substrate for skeletal muscle, that the
size of body carbohydrate stores is relatively limited and can be acutely manipulated by dietary intake,
and that the performance of prolonged (continuous or intermittent) high-intensity exercise can be
maintained by maintaining carbohydrate availability, while the inability to maintain carbohydrate
availability is associated with fatigue in the form of reduced work rates, and increased perception of
effort. The mechanisms by which CHO solutions can improve physical performance during high-
intensity, long-lasting exercise include glycogen sparing, provision of an exogenous muscle substrate,
prevention of hypoglycaemia, activation of reward centres in the central nervous system, and the
provision of ﬂuids to main hydration (Thomas et al., 2016).
The Panel considers that the mechanisms by which the consumption of CHO solutions during high-
intensity and long-lasting physical exercise could exert the claimed effect are well established.
Weighing the evidence
In weighing the evidence, the Panel took into account that the consumption of CHO solutions
providing about 30–60 g CHO/h, and up to about 90 g CHO/h when about one-third of the CHO were
in the form of fructose, during high-intensity exercise and long duration physical exercise consistently
improved physical performance in four studies conducted in non-fasting conditions with standardised
feeding protocols before the trial sessions (Mitchell et al., 1988, 1989; Langenfeld et al., 1994; Baur
et al., 2014). The Panel also took into account that the effect is supported by four studies conducted
in fasting conditions (Campbell et al., 2001; Currell and Jeukendrup, 2008; Robson-Ansley et al., 2009;
Smith et al., 2010) and by two studies in which the nutritional status of participants before the test
was not sufﬁciently speciﬁed (El-Sayed et al., 1995; MacLaren and Close, 2000). In addition, the
Panel considered that the mechanisms by which the consumption of CHO solutions during high-
intensity and long-lasting physical exercise could exert the claimed effect are well established (Thomas
et al., 2016).
The Panel concludes that a cause and effect relationship has been established between the
consumption of CHO solutions and the improvement of physical performance during high-intensity and
long-lasting physical exercise.
3.4. Panel’s comments on the proposed wording
The Panel considers that the following wording reﬂects the scientiﬁc evidence: ‘Carbohydrate
solutions can contribute to the improvement of physical performance during a high-intensity and long-
lasting physical exercise in healthy trained adults’.
3.5. Conditions and restrictions of use
In order to obtain the claimed effect, CHO solutions (containing glucose, mixtures of glucose and
fructose, sucrose and/or maltodextrins) should be consumed to provide between 30 and 60 g of CHO/h,
and up to 90 g CHO/h if fructose constitutes about 1/3 of the CHO mixture.
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The target population is healthy trained adults performing high-intensity (at least at 65% of the
VO2max) and long-lasting (at least 60 min) physical exercise.
4. Conclusions
On the basis of the data presented, the Panel concludes that:
• the food/constituent, CHO solutions (containing glucose, mixtures of glucose and fructose,
sucrose and/or maltodextrins), which are the subject of the health claim, are sufﬁciently
characterised in relation to the claimed effect.
• the claimed effect proposed by the applicant is ‘improvement of physical performance during a
high-intensity and long-lasting physical exercise’. The target population proposed by the
applicant is ‘healthy physically active, trained or well-trained adults (male and female) engaged
in a high-intensity exercise lasting more than one hour’. Improvement of physical performance
during a high-intensity and long-lasting physical exercise is a beneﬁcial physiological effect.
• a cause and effect relationship has been established between the consumption of CHO
solutions and the improvement of physical performance during high-intensity and long-lasting
physical exercise.
• the following wording reﬂects the scientiﬁc evidence: ‘Carbohydrate solutions can contribute to
the improvement of physical performance during a high-intensity and long-lasting physical
exercise in healthy trained adults’.
• in order to obtain the claimed effect, CHO solutions (containing glucose, mixtures of glucose
and fructose, sucrose and/or maltodextrins) should be consumed to provide between 30 and
60 g of CHO/h, and up to 90 g CHO/h if fructose constitutes about one-third of the CHO
mixture. The target population is healthy trained adults performing high-intensity (at least at
65% of the VO2max) and long-lasting (at least 60 min) physical exercise.
Steps taken by EFSA
Health claim application on ‘carbohydrate solutions’ and ‘improvement of physical performance
during endurance exercise’ pursuant to Article 13(5) of Regulation (EC) No 1924/2006 (Claim serial No:
0462_FR). Submitted by Specialised Nutrition Europe (SNE), Avenue des Nerviens, 9-31, 1040
Brussels, Belgium.
1) This application was received by EFSA on 10/8/2017.
2) The scope of the application was proposed to fall under a health claim based on newly
developed scientiﬁc evidence.
3) The scientiﬁc evaluation procedure started 22/9/2017.
4) On 16/11/2017, the Working Group on Claims of the NDA Panel agreed on a list of questions
for the applicant to provide additional information to accompany the application. The
scientiﬁc evaluation was suspended on 29/11/2017 and was restarted on 13/12/2017, in
compliance with Article 18(3) of Regulation (EC) No 1924/2006.
5) During its meeting on 7/2/2017, the NDA Panel, having evaluated the data, adopted an
opinion on the scientiﬁc substantiation of a health claim related to glycaemic carbohydrates
and improvement of physical performance during endurance exercise.
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